ScoreWhy is Nephros, Inc. ?
1
Poor Management Efficiency with a low ROE of 1.72%
- The company has been able to generate a Return on Equity (avg) of 1.72% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 17.67% of over the last 5 years
3
With a growth in Net Profit of 755%, the company declared Very Positive results in Jun 26
- ROCE(HY) Highest at 16.1%
- RAW MATERIAL COST(Y) Fallen by -6.46% (YoY)
- NET SALES(Q) Highest at USD 6.02 MM
4
With ROE of 11.70%, it has a expensive valuation with a 3.02 Price to Book Value
- Over the past year, while the stock has generated a return of 0.94%, its profits have risen by 112% ; the PEG ratio of the company is 0
5
High Institutional Holdings at 53.47%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Underperformed the market in the last 1 year
- The stock has generated a return of 0.94% in the last 1 year, much lower than market (S&P 500) returns of 15.76%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Nephros, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nephros, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nephros, Inc.
0.94%
1.11
86.57%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.03%
EBIT Growth (5y)
17.67%
EBIT to Interest (avg)
-2.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.40
Sales to Capital Employed (avg)
1.64
Tax Ratio
1.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.06%
ROCE (avg)
2.77%
ROE (avg)
1.72%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
3.02
EV to EBIT
22.47
EV to EBITDA
20.01
EV to Capital Employed
4.96
EV to Sales
1.37
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
22.07%
ROE (Latest)
11.70%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
ROCE(HY)
Highest at 16.1%
RAW MATERIAL COST(Y)
Fallen by -6.46% (YoY
NET SALES(Q)
Highest at USD 6.02 MM
OPERATING PROFIT(Q)
Highest at USD 1.24 MM
OPERATING PROFIT MARGIN(Q)
Highest at 20.64 %
PRE-TAX PROFIT(Q)
Highest at USD 1.21 MM
NET PROFIT(Q)
Highest at USD 1.2 MM
EPS(Q)
Highest at USD 0.11
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -1.34 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.75 times
Here's what is working for Nephros, Inc.
Pre-Tax Profit
At USD 1.21 MM has Grown at 514.21%
over average net sales of the previous four periods of USD 0.2 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 1.2 MM has Grown at 517.01%
over average net sales of the previous four periods of USD 0.19 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 6.02 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 6.02 MM has Grown at 25.85%
over average net sales of the previous four periods of USD 4.78 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 1.24 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 20.64 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 1.21 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 1.2 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.11
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -6.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nephros, Inc.
Operating Cash Flow
Lowest at USD -1.34 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 6.75 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Footer loading
